5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Syngene International Ltd.

•
syngeneintl.comBSE: 539268NSE: SYNGENE
Market Cap₹ 15,446 Cr.
Current Price
High / Low₹ 679 / 375
Stock P/E69.9
Book Value₹ 117
Price to Book3.31
Dividend Yield0.33 %
ROCE9.5 %
ROE6.7 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has consistently been profitable over the last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.36x)
  • Working capital cycle has improved - days down from 89 to 57
  • Company comfortably covers its interest (9.4x coverage)
  • Company generates healthy free cash flow

CONS

  • Recent results are weak - TTM profit is down 59.1% versus prior year
  • Promoter holding has decreased over last 2 years: -2.1pp
  • Company has delivered a poor profit growth of -4.8% over past five years
  • Operating margins have contracted to 24.3% from 31.5%
  • Recurring exceptional / one-off items are inflating headline profit

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareBusiness ServicesBusiness Support
Part ofNIFTY TOTAL MKTNIFTY SMLCAP 50NIFTY 500NIFTY SMLCAP 250NIFTY HEALTHCARE
S.No.Name
1.PFOCUS310.60209.2824188.720.00-457.78-514.4312668.151196.882.7423.76
2.SAGILITY45.1521.2821136.200.33216.8145.941963.4827.5913.8222.32
3.HORIZONIND55.65244.0316043.350.00-116.27—2005.46—3.3280.26
4.SYNGENE382.6569.8915446.400.33-9.00-110.38736.00-15.849.4812.34
5.INDGN578.0534.7413929.080.39116.20-0.171063.1039.7318.9216.39
6.IGIL314.2022.2713578.461.59165.7430.98370.7823.2277.0060.35
7.NESCO1102.7518.657769.970.6399.963.97211.809.5519.2348.33
8.LEAPIND144.55102.156367.950.00247.33—2034.13—9.3251.19
9.SPARC196.104.026363.870.00-20.7859.9439.92314.11163.94-85.17
10.SMARTWORKS530.60217.746069.060.0013.15413.27546.2544.0561.1263.33
11.JUSTDIAL665.1015.595656.610.00115.7438.44270.2716.2312.8826.17
12.LATENTVIEW252.5026.765228.850.0047.10-6.84286.8821.5516.6919.76
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
8089108549177908919441,0188749119171,036736
596656622600620650662674668711708733767
Operating Profit212254232317170240282344206200209303-31
OPM %26.22%27.92%27.12%34.56%21.50%26.99%29.87%33.75%23.60%21.91%22.81%29.27%-4.21%
24142616502120191815-551639
Interest10131113121312161213121210
Depreciation102105108111107111109106111116114112112
Profit before Tax1231511382091011371812401018528196-19
Tax %24.00%22.69%19.32%9.76%25.27%22.72%27.49%23.78%14.41%21.24%47.18%24.54%53.12%
Net Profit000076106131183876715148-9
2.332.902.784.701.892.643.274.562.161.670.373.68-0.22

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
1,4231,8262,0122,1842,6043,1933,4893,6423,7393,600
1,0331,2901,4081,5311,8642,2602,4742,6012,8272,919
Operating Profit3905366036537409331,0141,042912681
OPM %27.44%29.34%29.99%29.90%28.43%29.21%29.08%28.60%24.40%18.92%
13676167118787380104015
Interest23323528244547534947
Depreciation131164219274310366426433453454
Profit before Tax372415517469484594621660411290
Tax %18.01%20.17%20.27%13.70%18.29%21.77%17.85%24.81%22.93%23.90%
Net Profit305332412405396464510496317221
EPS15.438.3610.3510.119.8211.5112.6912.337.86—
Dividend Payout %6.55%3.02%0.00%0.00%10.13%10.80%9.85%10.14%15.90%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
11%
3 Years:
5%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
-5%
3 Years:
-12%

STOCK PRICE CAGR

10 Years:
5%
5 Years:
-10%
3 Years:
-23%
1 Year:
-42%

RETURN ON EQUITY

10 Years:
—
5 Years:
12%
3 Years:
10%
Last Year:
7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Jun 25

₹ 0.12

Rs.1.2500 per share(12.5%)Final Dividend

2025

Jun 27

₹ 0.12

Rs.1.2500 per share(12.5%)Final Dividend

2024

Jun 28

₹ 0.12

Rs.1.2500 per share(12.5%)Final Dividend

2023

Jun 30

₹ 0.07

Rs.0.7500 per share(7.5%)Special Dividend

2023

Jun 30

₹ 0.05

2022

Jun 30

₹ 0.05

Rs.0.5000 per share(5%)Final Dividend

2022

Jun 30

₹ 0.05

19/08/2022 Equity Rs.0.5000 per share(5%)Special Dividend

2018

Jul 17

₹ 0.10

Rs.1.0000 per share(10%)Final Dividend

2017

Jul 20

₹ 0.10

03/08/2017 Equity Rs.1.0000 per share(10%)Final Dividend

2016

Mar 17

₹ 0.10

31/03/2016 Equity Interim Dividend

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital200200400400401401402402403
1,4921,7401,7372,3442,8093,1513,7874,2454,342
8761,0301,0951,1411,2611,067751749655
Trade Payables204224222242233258256352348
3454195866677948839161,0181,206
Total Liabilities3,1173,6124,0404,7945,4985,7616,1116,7666,954
1,0301,3371,9842,1632,3542,6192,8092,7672,968
Capital Work in Progress1552742342373461778371,2611,040
1587167767021,034918548647741
86432560179333238156141
000000442527509
Cash & Bank967437282643518532564787833
7208057399891,0661,183674622721
Total Assets3,1173,6124,0404,7945,4985,7616,1116,7666,954

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
5277267847856869601,0421,168915
Cash from Investing-349-646-428-628-612-656-496-745-860
Cash from Financing-79-72-22658-31-342-551-142-215
18-8823131-62-175-5281-160

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
54.7254.7252.7452.7452.6852.6852.6852.6852.59
20.6420.7220.6519.4716.5016.3114.9613.9111.82
16.7817.4919.5221.5024.0524.6225.8326.4428.01
Government0.000.000.000.000.000.000.000.000.00
7.867.077.096.296.776.396.516.987.58

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-12
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-12 - Syngene International Limited has informed the Exchange about Schedule of meet

2026-09-11
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-11 - Syngene International Limited has informed the Exchange about Schedule of meet

2026-09-10
General Updates

2026-09-10 - Syngene International Limited has informed the Exchange about the Communication regarding remittance of final dividend for the FY 2025-26.

2026-09-01
Updates

2026-09-01 - Syngene International Limited has informed the Exchange regarding Grant of Performance Share Units under Syngene Long Term Incentive Performance Share Plan (PSP) 2023 (Plan).

2026-08-25
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-25 - Syngene International Limited has informed the Exchange about Schedule of meet

2026-08-24
Acquisition

2026-08-24 - Syngene International Limited has informed the Exchange about Acquisition

2026-08-24
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-24 - Syngene International Limited has informed the Exchange about Schedule of meet

2026-08-10
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-10 - Syngene International Limited has informed the Exchange about Schedule of meet

2026-08-06
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-06 - Syngene International Limited has informed the Exchange about Transcript

News

Recent coverage and analyst commentary for SYNGENE

Loading news…

🤖

AI Stock Analyst

Syngene International Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login